Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Millions	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Fixed maturity available-for-sale securities, at fair value
Amortized Cost	$ 101,462	$ 97,415
Allowance for credit losses	110	46	$ 19	$ 22
Mortgage loans on real estate, net of allowance for credit losses
Fair value	$ 199	$ 232
Stockholders’ Equity
Preferred stock, authorized (in shares)	10,000,000	10,000,000
Preferred stock, issued (in shares)	40,000	40,000
Preferred stock, outstanding (in shares)	40,000	40,000
Common stock, authorized (in shares)	800,000,000	800,000,000
Common stock, issued (in shares)	190,051,477	170,380,646
Common stock, outstanding (in shares)	190,051,477	170,380,646	169,666,137	169,220,511
Series C Preferred Stock
Stockholders’ Equity
Preferred stock, authorized (in shares)	20,000	20,000
Preferred stock, issued (in shares)	20,000	20,000
Preferred stock, outstanding (in shares)	20,000	20,000
Series D Preferred Stock
Stockholders’ Equity
Preferred stock, authorized (in shares)	20,000	20,000
Preferred stock, issued (in shares)	20,000	20,000
Preferred stock, outstanding (in shares)	20,000	20,000